BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 24043776)

  • 1. Molecular basis for pH-dependent mucosal dehydration in cystic fibrosis airways.
    Garland AL; Walton WG; Coakley RD; Tan CD; Gilmore RC; Hobbs CA; Tripathy A; Clunes LA; Bencharit S; Stutts MJ; Betts L; Redinbo MR; Tarran R
    Proc Natl Acad Sci U S A; 2013 Oct; 110(40):15973-8. PubMed ID: 24043776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPLUNC1 degradation by the cystic fibrosis mucosal environment drives airway surface liquid dehydration.
    Webster MJ; Reidel B; Tan CD; Ghosh A; Alexis NE; Donaldson SH; Kesimer M; Ribeiro CMP; Tarran R
    Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30190268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the SPLUNC1 ENaC-inhibitory domain yields novel strategies to treat sodium hyperabsorption in cystic fibrosis airway epithelial cultures.
    Hobbs CA; Blanchard MG; Alijevic O; Tan CD; Kellenberger S; Bencharit S; Cao R; Kesimer M; Walton WG; Henderson AG; Redinbo MR; Stutts MJ; Tarran R
    Am J Physiol Lung Cell Mol Physiol; 2013 Dec; 305(12):L990-L1001. PubMed ID: 24124190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPLUNC1 is an allosteric modulator of the epithelial sodium channel.
    Kim CS; Ahmad S; Wu T; Walton WG; Redinbo MR; Tarran R
    FASEB J; 2018 May; 32(5):2478-2491. PubMed ID: 29295861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin B contributes to Na+ hyperabsorption in cystic fibrosis airway epithelial cultures.
    Tan CD; Hobbs C; Sameni M; Sloane BF; Stutts MJ; Tarran R
    J Physiol; 2014 Dec; 592(23):5251-68. PubMed ID: 25260629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian short palate lung and nasal epithelial clone 1 (SPLUNC1) in pH-dependent airway hydration.
    Tarran R; Redinbo MR
    Int J Biochem Cell Biol; 2014 Jul; 52():130-5. PubMed ID: 24631954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis lung disease.
    Moore PJ; Tarran R
    Expert Opin Ther Targets; 2018 Aug; 22(8):687-701. PubMed ID: 30028216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavage.
    Garcia-Caballero A; Rasmussen JE; Gaillard E; Watson MJ; Olsen JC; Donaldson SH; Stutts MJ; Tarran R
    Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11412-7. PubMed ID: 19541605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPX-101 is stable in and retains function after exposure to cystic fibrosis sputum.
    Sesma JI; Wu B; Stuhlmiller TJ; Scott DW
    J Cyst Fibros; 2019 Mar; 18(2):244-250. PubMed ID: 29936069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid inhibits ENaC and Na/K pump activity to restore airway surface liquid height in cystic fibrosis bronchial epithelial cells.
    Mroz MS; Harvey BJ
    Steroids; 2019 Nov; 151():108461. PubMed ID: 31344409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential epithelial expression of the putative innate immune molecule SPLUNC1 in cystic fibrosis.
    Bingle L; Barnes FA; Cross SS; Rassl D; Wallace WA; Campos MA; Bingle CD
    Respir Res; 2007 Nov; 8(1):79. PubMed ID: 17988392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thickness of the airway surface liquid layer in the lung is affected in cystic fibrosis by compromised synergistic regulation of the ENaC ion channel.
    Olivença DV; Fonseca LL; Voit EO; Pinto FR
    J R Soc Interface; 2019 Aug; 16(157):20190187. PubMed ID: 31455163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPLUNC1 expression reduces surface levels of the epithelial sodium channel (ENaC) in Xenopus laevis oocytes.
    Rollins BM; Garcia-Caballero A; Stutts MJ; Tarran R
    Channels (Austin); 2010; 4(4):255-9. PubMed ID: 20519934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble mediators, not cilia, determine airway surface liquid volume in normal and cystic fibrosis superficial airway epithelia.
    Tarran R; Trout L; Donaldson SH; Boucher RC
    J Gen Physiol; 2006 May; 127(5):591-604. PubMed ID: 16636206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a SPLUNC1-derived peptide for the treatment of cystic fibrosis lung disease.
    Terryah ST; Fellner RC; Ahmad S; Moore PJ; Reidel B; Sesma JI; Kim CS; Garland AL; Scott DW; Sabater JR; Carpenter J; Randell SH; Kesimer M; Abraham WM; Arendshorst WJ; Tarran R
    Am J Physiol Lung Cell Mol Physiol; 2018 Jan; 314(1):L192-L205. PubMed ID: 28982737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the epithelial Na+ channel and airway surface liquid volume by serine proteases.
    Gaillard EA; Kota P; Gentzsch M; Dokholyan NV; Stutts MJ; Tarran R
    Pflugers Arch; 2010 Jun; 460(1):1-17. PubMed ID: 20401730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SPLUNC1-βENaC complex prevents Burkholderia cenocepacia invasion in normal airway epithelia.
    Ahmad S; Kim CSK; Tarran R
    Respir Res; 2020 Jul; 21(1):190. PubMed ID: 32680508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium.
    Zhang L; Button B; Gabriel SE; Burkett S; Yan Y; Skiadopoulos MH; Dang YL; Vogel LN; McKay T; Mengos A; Boucher RC; Collins PL; Pickles RJ
    PLoS Biol; 2009 Jul; 7(7):e1000155. PubMed ID: 19621064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cigarette smoke modifies and inactivates SPLUNC1, leading to airway dehydration.
    Moore PJ; Reidel B; Ghosh A; Sesma J; Kesimer M; Tarran R
    FASEB J; 2018 Jun; 32(12):fj201800345R. PubMed ID: 29890087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ENaC inhibitors and airway re-hydration in cystic fibrosis: state of the art.
    Althaus M
    Curr Mol Pharmacol; 2013 Mar; 6(1):3-12. PubMed ID: 23547930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.